{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T02:28:49Z","timestamp":1786328929119,"version":"build-2736575974"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Evidence regarding continuation versus withdrawal of immunosuppressive agents during antiviral treatment of cytomegalovirus (CMV) colitis complicating ulcerative colitis (UC) remains limited. We compared molecular remission, clinical outcomes, and relapse according to immunosuppressive-therapy management. Materials and Methods: This prospective, non-randomized, single-center cohort included 44 hospitalized adults with UC and CMV colitis treated with intravenous ganciclovir. Patients were managed according to a clinician-selected strategy of temporary discontinuation (n = 24) or continuation (n = 20) of immunosuppressive therapy. Molecular remission, the primary outcome, was defined as undetectable tissue CMV DNA at day 14. Results: Both groups demonstrated significant clinical and endoscopic improvement. The continuation group had higher residual CMV DNA levels at day 14 (p = 0.003) and more adverse events (p = 0.019). Clinical remission, endoscopic remission, and one-year relapse rates were comparable. Multivariable logistic regression showed that continuation of immunosuppressive therapy was associated with reduced molecular remission (OR 0.26, 95% CI 0.07\u20130.98; p = 0.045). Corticosteroid exposure was confined to the continuation group (7\/20 vs. 0\/24), raising the possibility of substantial residual confounding. Conclusions: In this exploratory cohort, clinician-selected continuation of immunosuppressive therapy was associated with a lower likelihood of day-14 molecular remission and more frequent adverse events, without demonstrable additional clinical or endoscopic benefit. However, the observed association may have been influenced by corticosteroid exposure and should not be interpreted as a class-wide effect of immunosuppressive therapy. These hypothesis-generating findings require confirmation in adequately powered multicenter studies before informing routine clinical practice.<\/jats:p>","DOI":"10.3390\/medicina62081532","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:20:03Z","timestamp":1786324803000},"page":"1532","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunosuppressive-Therapy Management and Day-14 Molecular Remission in Ulcerative Colitis Complicated by Cytomegalovirus Colitis: An Exploratory Prospective Cohort Study"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7546-4318","authenticated-orcid":false,"given":"Zeki","family":"Islamoglu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, University of Health Sciences Kocaeli City Hospital, 41285 Izmit, Kocaeli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Research and Training Hospital, Kocaeli University, 41380 Izmit, Kocaeli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Erkan","family":"Duman","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Research and Training Hospital, Kocaeli University, 41380 Izmit, Kocaeli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goktug","family":"Sirin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Research and Training Hospital, Kocaeli University, 41380 Izmit, Kocaeli, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sayan","sequence":"additional","affiliation":[{"name":"PCR Unit, Clinical Laboratory, Research and Training Hospital, Kocaeli University, 41380 Izmit, Kocaeli, Turkey"},{"name":"DESAM Research Institute, Near East University, 99138 Nicosia, North Cyprus, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ibd.20498","article-title":"Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy","volume":"14","author":"Vega","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative colitis in adults: A review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1099\/jmm.0.45629-0","article-title":"Infection with cytomegalovirus in patients with inflammatory bowel disease","volume":"53","author":"Kishore","year":"2004","journal-title":"J. Med. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jentzer, A., Veyrard, P., Roblin, X., Saint-Sardos, P., Rochereau, N., Paul, S., Bourlet, T., Pozzetto, B., and Pillet, S. (2020). Cytomegalovirus and inflammatory bowel diseases (IBD) with a special focus on the link with ulcerative colitis (UC). Microorganisms, 8.","DOI":"10.3390\/microorganisms8071078"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MCG.0b013e3182160c9c","article-title":"The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection","volume":"46","author":"Kim","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1007\/s10620-015-3733-6","article-title":"Relationship between cytomegalovirus infection and steroid resistance in inflammatory bowel disease: A meta-analysis","volume":"60","author":"Wu","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3748\/wjg.v19.i1.17","article-title":"Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease","volume":"19","author":"Garrido","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3748\/wjg.v21.i6.1915","article-title":"Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease","volume":"21","author":"Ciccocioppo","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cgh.2014.05.026","article-title":"A model for identifying cytomegalovirus in patients with inflammatory bowel disease","volume":"13","author":"McCurdy","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/jcm13010130","article-title":"Cytomegalovirus infection: An underrated target in inflammatory bowel disease treatment","volume":"13","author":"Maresca","year":"2024","journal-title":"J. Clin. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MCG.0000000000000758","article-title":"Corticosteroids and thiopurines, but not tumor necrosis factor antagonists, are associated with cytomegalovirus reactivation in inflammatory bowel disease","volume":"51","author":"Shukla","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cetin, E., Gunel, B., and Yilmaz, M. (2026). Effects of different pneumoperitoneum pressures on the upper airway assessed by ultrasonography: A prospective, randomized, observer-blinded clinical study. BMC Anesthesiol., 26.","DOI":"10.1186\/s12871-026-03801-3"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Truelove","year":"1955","journal-title":"Br. Med. J."},{"key":"ref_15","first-page":"997","article-title":"Improved Mayo Endoscopic Score has a higher value for evaluating clinical severity of ulcerative colitis","volume":"42","author":"Song","year":"2022","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00384-023-04347-3","article-title":"Comparison of the Toronto IBD Global Endoscopic Reporting (TIGER) score, Mayo endoscopic score (MES), and ulcerative colitis endoscopic index of severity (UCEIS)","volume":"38","author":"Xu","year":"2023","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100512","DOI":"10.1016\/j.medj.2024.09.001","article-title":"Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitis","volume":"6","author":"Solitano","year":"2025","journal-title":"Med"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity Analysis in Observational Research: Introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3904\/kjim.2017.087","article-title":"Approach to cytomegalovirus infections in patients with ulcerative colitis","volume":"32","author":"Park","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.34172\/aim.2024.40","article-title":"Cytomegalovirus infection in adult patients with inflammatory bowel disease: A literature review","volume":"27","author":"Sanat","year":"2024","journal-title":"Arch. Iran. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4291\/wjgp.v4.i1.18","article-title":"Cytomegalovirus positive ulcerative colitis: A single center experience and literature review","volume":"4","author":"Kopylov","year":"2013","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3748\/wjg.v22.i6.2030","article-title":"Cytomegalovirus and ulcerative colitis: Place of antiviral therapy","volume":"22","author":"Pillet","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kim, Y.J., Lee, J.Y., and Kim, H.J. (2025). Long-term clinical outcomes of ulcerative colitis with concurrent endoscopic and histologic remission. Medicina, 61.","DOI":"10.3390\/medicina61111968"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/INF.0000000000001724","article-title":"Cytomegalovirus infection in pediatric severe ulcerative colitis\u2014A multicenter study from the Pediatric IBD Porto Group of ESPGHAN","volume":"37","author":"Cohen","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hsieh, C.R., Wu, R.C., and Kuo, C.J. (2024). Adequate antiviral treatment lowers overall complications of cytomegalovirus colitis among inpatients with inflammatory bowel diseases. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09317-w"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tominaga, K., Kanazawa, M., Tanaka, T., and Hiraishi, H. (2020). A case of lung abscess caused by double immunosuppressive therapy to treat ulcerative colitis. Medicina, 56.","DOI":"10.3390\/medicina56110595"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1097\/MIB.0000000000000958","article-title":"Toward an algorithm for the diagnosis and management of CMV in patients with colitis","volume":"22","author":"Beswick","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjaa036","article-title":"Ulcerative colitis and cytomegalovirus infection: From A to Z","volume":"14","author":"Mourad","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","article-title":"ACG Clinical Guideline Update: Ulcerative Colitis in Adults","volume":"120","author":"Rubin","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12985-024-02467-y","article-title":"A diagnostic dilemma: Cytomegalovirus colitis as an uncommon comorbidity in inflammatory bowel disease: A case report","volume":"21","author":"Alhalabi","year":"2024","journal-title":"Virol. J."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1532\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:48:55Z","timestamp":1786326535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081532"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081532","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}